Inicio Área de profesionales Artículos publicados Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study

Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study

Correo electrónico Imprimir

Antón , A. Ruiz, M. A. Seguí, L. Calvo, M. Muñoz, J. Lao, F. Sancho and L. Fernández. Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. Annals of Oncology 2009; 20(3):454-459. 

Para más información vaya al siguiente enlace:

http://annonc.oxfordjournals.org/content/20/3/454